Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

NCT00004888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

NIH

Sponsor class

Conditions

Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: docetaxel
BIOLOGICAL: trastuzumab
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)